| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
10,381 |
8,822 |
$1.28M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
8,045 |
6,599 |
$1.23M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,196 |
830 |
$187K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
1,013 |
313 |
$138K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,562 |
3,072 |
$136K |
| 80053 |
Comprehensive metabolic panel |
13,982 |
11,722 |
$133K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
14,495 |
12,014 |
$101K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,027 |
883 |
$83K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,491 |
1,204 |
$69K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,805 |
1,378 |
$62K |
| 71045 |
Radiologic examination, chest; single view |
456 |
362 |
$46K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
631 |
540 |
$45K |
| 71046 |
Radiologic examination, chest; 2 views |
477 |
406 |
$38K |
| 36415 |
Collection of venous blood by venipuncture |
9,437 |
6,673 |
$29K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,554 |
2,376 |
$29K |
| 81003 |
|
5,085 |
4,270 |
$21K |
| 80061 |
Lipid panel |
2,413 |
2,271 |
$21K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
176 |
161 |
$18K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
214 |
190 |
$14K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,060 |
838 |
$13K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
737 |
516 |
$13K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,826 |
1,734 |
$12K |
| 94761 |
|
130 |
103 |
$9K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,568 |
1,281 |
$9K |
| 83735 |
|
1,698 |
1,491 |
$8K |
| 74021 |
|
135 |
81 |
$8K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
362 |
350 |
$8K |
| 84484 |
|
719 |
586 |
$6K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
48 |
40 |
$6K |
| 87430 |
|
663 |
539 |
$5K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
379 |
291 |
$3K |
| 80305 |
|
400 |
363 |
$3K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
71 |
12 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
568 |
430 |
$3K |
| 86804 |
|
223 |
208 |
$3K |
| 81025 |
|
348 |
289 |
$3K |
| 83605 |
|
325 |
277 |
$2K |
| 82553 |
|
487 |
399 |
$2K |
| 85730 |
|
630 |
534 |
$2K |
| 70450 |
Computed tomography, head or brain; without contrast material |
18 |
16 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
182 |
132 |
$2K |
| 82550 |
|
490 |
402 |
$2K |
| 85610 |
|
659 |
560 |
$1K |
| 83880 |
|
125 |
97 |
$1K |
| 82607 |
|
140 |
132 |
$1K |
| 83690 |
|
125 |
110 |
$1K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
29 |
27 |
$931.23 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
26 |
25 |
$694.70 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
26 |
25 |
$694.70 |
| 87081 |
|
100 |
91 |
$673.32 |
| 87807 |
|
29 |
22 |
$672.34 |
| 82150 |
|
76 |
67 |
$568.51 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
39 |
12 |
$477.36 |
| 82728 |
|
26 |
25 |
$346.65 |
| 87186 |
|
31 |
25 |
$326.85 |
| 84481 |
|
24 |
24 |
$296.90 |
| 80306 |
|
33 |
28 |
$291.38 |
| 83550 |
|
25 |
24 |
$213.54 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
21 |
20 |
$209.04 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
68 |
29 |
$197.67 |
| 86140 |
|
47 |
41 |
$186.65 |
| 83540 |
|
25 |
24 |
$158.08 |
| 85652 |
|
65 |
56 |
$151.20 |
| 94726 |
|
12 |
12 |
$141.84 |
| 82043 |
|
27 |
25 |
$116.70 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
13 |
12 |
$88.60 |
| 84436 |
|
24 |
24 |
$80.38 |
| 84439 |
|
12 |
12 |
$70.00 |
| 85018 |
|
64 |
50 |
$32.34 |
| 85014 |
|
64 |
50 |
$32.34 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
23 |
13 |
$27.41 |
| 82465 |
|
13 |
12 |
$25.55 |
| 85379 |
|
17 |
15 |
$12.52 |
| J3490 |
Unclassified drugs |
51 |
26 |
$3.83 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
31 |
24 |
$1.53 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
12 |
12 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
66 |
47 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
46 |
24 |
$0.00 |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
20 |
19 |
$0.00 |